Boston Medical Group review

Two things here are better than average and one is worse, and they are worth separating. Better: this is one of very few sellers that will tell a reader what the wider market costs, quoting the brand-name products in the thousands per month and non-brand programs at a few hundred. That gives someone a frame of reference instead of only a sales figure, and most of this category would rather you had no frame at all. Better again: treatment is described in named phases with doses stated in milligrams per week, so a reader can see an initiation dose set against a maintenance one — genuinely useful detail, and rarer here than it ought to be. Worse: the headline price does not survive its own footnote. The site advertises starting from a monthly figure, and the asterisk attached prices a complete twelve-week program at a total working out roughly a third higher per month, because a telemedicine platform fee sits on top of the medication line. None of that is concealed — it is written on the same page — but it is written in the footnote while the headline carries the smaller number, and the headline is what a reader remembers.

Vs median

Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Billed separately

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Boston Medical Group dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is billed separately.

Two things here are better than average and one is worse. Better: this is one of very few sellers that will tell a reader what the wider market costs, quoting brand-name products at a thousand to four thousand dollars a month and non-brand programs at a few hundred, which gives someone a frame of reference rather than only a sales figure. Better again: it describes treatment in phases and states doses in milligrams per week, so a reader can see what an initiation dose is against a maintenance one — genuinely useful, and rarer than it should be. Worse: the headline price does not survive its own footnote. The site advertises starting from a figure per month, and the asterisk attached to it prices a complete twelve-week program at a total that works out closer to a third more per month, because a telemedicine platform fee sits on top of the medication line. Nothing about that is hidden — it is written down, on the same page — but it is written in the footnote and not in the headline, and the headline is the number a reader carries away.

The advertised monthly figure excludes a platform fee that its own footnote adds back.

• The twelve-week total works out well above the headline rate per month.
• No compounding pharmacy is named.

Boston Medical Group is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Titrating up from a microdose
• The true annual cost of a plan
• Titration planner